Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

α‐Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives
Obada M. Alzghool, Guus A.M.S. van Dongen, Elsmarieke van de Giessen, et al.
Movement Disorders (2022) Vol. 37, Iss. 5, pp. 936-948
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research
Tanya Simuni, Lana M. Chahine, Kathleen L. Poston, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 178-190
Closed Access | Times Cited: 219
The use of neuroimaging techniques in the early and differential diagnosis of dementia
Leonidas Chouliaras, John T. O’Brien
Molecular Psychiatry (2023) Vol. 28, Iss. 10, pp. 4084-4097
Open Access | Times Cited: 50
Research diagnostic criteria for mild cognitive impairment with Lewy bodies: A systematic review and meta‐analysis
Paul C. Donaghy, Claudia Carrarini, Daniel Ferreira, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 7, pp. 3186-3202
Open Access | Times Cited: 27
Structural mechanism for specific binding of chemical compounds to amyloid fibrils
Youqi Tao, Wencheng Xia, Qinyue Zhao, et al.
Nature Chemical Biology (2023) Vol. 19, Iss. 10, pp. 1235-1245
Closed Access | Times Cited: 27
Synaptic loss and its association with symptom severity in Parkinson’s disease
Sophie Holmes, Praveen Honhar, Sule Tinaz, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Re-examining the pathobiological basis of gait dysfunction in Parkinson’s disease
Newton Cho, Lorraine V. Kalia, Suneil K. Kalia
Trends in Neurosciences (2025)
Closed Access | Times Cited: 1
Toward a biological definition of neuronal and glial synucleinopathies
Claudio Soto, Brit Mollenhauer, Oskar Hansson, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 1
How should we be using biomarkers in trials of disease modification in Parkinson’s disease?
Nirosen Vijiaratnam, Thomas Foltynie
Brain (2023) Vol. 146, Iss. 12, pp. 4845-4869
Open Access | Times Cited: 18
Single-domain antibody–based noninvasive in vivo imaging of α-synuclein or tau pathology
Yixiang Jiang, Yan Lin, Senthilkumar Krishnaswamy, et al.
Science Advances (2023) Vol. 9, Iss. 19
Open Access | Times Cited: 16
Morphological basis of Parkinson disease-associated cognitive impairment: an update
K. A. Jellinger
Journal of Neural Transmission (2022) Vol. 129, Iss. 8, pp. 977-999
Closed Access | Times Cited: 26
Biomarkers in Parkinson’s Disease
Sarah M. Brooker, Paulina González-Latapí
Neurologic Clinics (2025) Vol. 43, Iss. 2, pp. 229-248
Closed Access
Positron emission tomography molecular imaging for pathological visualization in multiple system atrophy
Lin Dong, Rui Zhou, Jinyun Zhou, et al.
Neurobiology of Disease (2025), pp. 106828-106828
Open Access
In Vivo Positron Emission Tomography Imaging of α‐Synuclein: A Major Breakthrough
Sameh Ben Hadj Hassen, Véronique Sgambato‐Faure
Movement Disorders (2025)
Closed Access
A Novel Brain PET Radiotracer for Imaging Alpha Synuclein Fibrils in Multiple System Atrophy
Ho Young Kim, Wai Kit Chia, Chia‐Ju Hsieh, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 17, pp. 12185-12202
Closed Access | Times Cited: 10
The role of exosomes in the diagnosis of Parkinson's disease
Qingqing Shi, Wei Kang, Zhijun Liu, et al.
Heliyon (2023) Vol. 9, Iss. 10, pp. e20595-e20595
Open Access | Times Cited: 9
Neuroimaging biomarkers in the biological definition of Parkinson’s disease and dementia with Lewy bodies – EANM position on current state, unmet needs and future perspectives
Matthias Brendel, Eric Guedj, Igor Yakushev, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 12, pp. 3496-3500
Open Access | Times Cited: 3
Biomarkers of Parkinson's disease in perspective of early diagnosis and translation of neurotrophic therapies
Raimo K. Tuominen, Juho‐Matti Renko
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 135, Iss. 3, pp. 271-284
Open Access | Times Cited: 3
Molecular Imaging in Parkinsonian Disorders—What’s New and Hot?
Stéphane Prange, Hendrik Theis, Magdalena Banwinkler, et al.
Brain Sciences (2022) Vol. 12, Iss. 9, pp. 1146-1146
Open Access | Times Cited: 13
Preclinical Evaluation of Novel PET Probes for Dementia
Romy Cools, Kobe Kerkhofs, Renan C.F. Leitao, et al.
Seminars in Nuclear Medicine (2023) Vol. 53, Iss. 5, pp. 599-629
Closed Access | Times Cited: 7
Development of Pyridothiophene Compounds for PET Imaging of α‐Synuclein
Anna Pees, Junchao Tong, Saritha Birudaraju, et al.
Chemistry - A European Journal (2024) Vol. 30, Iss. 23
Open Access | Times Cited: 2
Radionuclide Imaging of the Neuroanatomical and Neurochemical Substrate of Cognitive Decline in Parkinson’s Disease
Samuel Booth, Ji Hyun Ko
Nuclear Medicine and Molecular Imaging (2024) Vol. 58, Iss. 4, pp. 213-226
Closed Access | Times Cited: 2
A dual target molecular magnetic resonance imaging probe for noninvasive profiling of pathologic alpha-synuclein and microgliosis in a mouse model of Parkinson’s disease
Xianwei Sun, Andrew Badachhape, Prajwal Bhandari, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
Memories and mimics: unveiling the potential of FDG-PET in guiding therapeutic approaches for neurodegenerative cognitive disorders
Brendan Huang, Sara Sawicki, Carolyn Habiger, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 2
Selecting the Best Animal Model of Parkinson’s Disease for Your Research Purpose: Insight from in vivo PET Imaging Studies
Caroline Cristiano Real, Karina Henrique Binda, Majken Borup Thomsen, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 5, pp. 1241-1272
Open Access | Times Cited: 6
One-Pot Radiosynthesis of [18F]Anle138b—5-(3-Bromophenyl)-3-(6-[18F]fluorobenzo[d][1,3]dioxol-5-yl)-1H-pyrazole—A Potential PET Radiotracer Targeting α-Synuclein Aggregates
Viktoriya V. Orlovskaya, О. С. Федорова, Н. Б. Викторов, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2732-2732
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top